Unravelling the Role of SGLT2 Inhibitors for Managing Diabetes, Renal Disease, and CVD

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science

Share Unravelling the Role of SGLT2 Inhibitors for Managing Diabetes, Renal Disease, and CVD

Sign up to save your podcasts

Unravelling the Role of SGLT2 Inhibitors for Managing Diabetes, Renal Disease, and CVD

Unravelling the Role of SGLT2 Inhibitors for Managing Diabetes, Renal Disease, and CVD

More shows like PeerVoice Endocrinology & Metabolic Disorders Video

PeerVoice Oncology & Haematology Audio

PeerVoice Oncology & Haematology Video

PeerVoice Heart & Lung Audio

PeerVoice Heart & Lung Video

PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice Digestive Diseases Video

PeerVoice Immunology & Infectious Disease Video

PeerVoice Immunology & Infectious Disease Audio

PeerVoice Internal Medicine Audio

PeerVoice Internal Medicine Video